AbstractObjective To evaluate gender- and geography-based differences in industry payments to U.S. gynecologic oncologists and to characterize temporal trends in payments across therapeutic classes. Methods We conducted a cross-sectional analysis of the Centers for Medicare p p Conclusions Industry payments to gynecologic oncologists demonstrate persistent gender and geographic diffrences and reflect evolving therapeutic priorities within the field. Increased transparency and proactive efforts are needed to promote balanced access to industry-sponsored opportunities as novel treatments emerge.
Levin et al. (Wed,) studied this question.